Sunitinib Malate(Sutent) CAS: 341031-54-7

• Post Date:

  Sep 23,2016

• Expiry Date:

  Mar 22,2017

• Detailed Description:

  Cas No. :341031-54-7 Quantity: 0.01Kilograms
  Price:1.25 USD Kilograms
  Sunitinib Malate(Sutent) CAS: 341031-54-7
  E:steroidcn at ycgmp.com
  Sky:live:bella881030
  unitinib Malate CAS 341031-54-7 Anti-Cancer
  key words:Sunitinib Malate, CAS 341031-54-7, Anti-Cancer
  
  *.Basic info:
  product name: Sunitinib malate
  
  Chinese alias: N- (2- (two ethyl amino) ethyl) -5- ((Z) - (5- -1,2- two -2- fluoride hydrogen oxygen generation -3H- indole -3- subunit) methyl) -2,4- two methyl -1H- pyrrole -3- formamide (2S) - hydroxy acid salt; sunitinib malate; sunitinib malate
  
  English name: N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene) methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate
  
  CAS 341031-54-7
  
  molecular formula: C22H27FN4O2.C4H6O5
  
  Molecular weight: 532.566
  
  Appearance: white powder
  
  
  Melting point: 189ºC~191ºC
  
  Assay: 99%
  
  Packing: 1kg aluminum foil bag or packaged according to customer requirements
  
  MOQ: 10g
  
  supply ability: mass stock
  
  *.Application:
  Sunitinib malate by preventing cancer cells of blood and nutrients needed for growth play a role in the treatment. Clinical trials show that the medicine, can delay the gastrointestinal stromal tumor growth speed, and can reduce the size of renal cell cancer. Sunitinib malate is the first to selectively target multiple tyrosine kinase receptor model targeting drugs, combined with the suspension to the anti angiogenic blood supply of tumor cells and tumor directly attack the tumor cell two mechanisms. It represents a new round of the advent of targeted therapies, which can directly attack the tumor toxicity, nor conventional chemotherapy.

• CAS Registry Number:

  341031-54-7

• Synonyms:

  ;SUNITINIB MALEATE;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1);Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1);N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;(2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);2-hydroxypentanedioic acid - N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxamide (1:1);Sunitinib Mablate;

• Molecular Formula:

  C₂₈H₃₈N₄O₇

• Molecular Weight:

  542.62392

• Molecular Structure:

  

• Company:

  Gongchuang Technology Co.,Ltd     [ China ]        

• Contact:

  Bella Lee

• Tel:

  86-27-50755950

• Fax:

• Email:

  steroidcn@ycgmp.com